Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Getting to the Heart of the Matter: A 20-Year-Old Man With Fever, Rash, and Chest Pain.
Open Forum Infect Dis. 2017 Dec 22;5(1):ofx272. doi: 10.1093/ofid/ofx272. eCollection 2018 Jan.
Open Forum Infect Dis. 2017.
PMID: 29399597
Free PMC article.
Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms.
Kopmar NE, Gooley T, Curley N, Russell K, Shaw C, Schonhoff K, Lim J, Halpern AB, Walter RB, Scott BL, Appelbaum J, Hendrie PC, Estey EH, Percival MM.
Kopmar NE, et al.
Leuk Lymphoma. 2023 May;64(5):1057-1059. doi: 10.1080/10428194.2023.2185087. Epub 2023 Mar 9.
Leuk Lymphoma. 2023.
PMID: 36896478
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
New drug approvals in acute myeloid leukemia: an unprecedented paradigm shift.
Kopmar NE, Estey EH.
Kopmar NE, et al.
Clin Adv Hematol Oncol. 2019 Oct;17(10):569-575.
Clin Adv Hematol Oncol. 2019.
PMID: 31730583
Review.
Item in Clipboard
Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies.
Kopmar NE, Othus M, Gardner KM, Shaw C, Halpern AB, Scott BL, Hendrie PC, Walter RB, Becker PS, Estey EH, Percival MM.
Kopmar NE, et al.
Leukemia. 2022 Apr;36(4):1164-1166. doi: 10.1038/s41375-022-01509-0. Epub 2022 Jan 20.
Leukemia. 2022.
PMID: 35058596
No abstract available.
Item in Clipboard
How I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia.
Kopmar NE, Cassaday RD.
Kopmar NE, et al.
Blood. 2023 Mar 23;141(12):1379-1388. doi: 10.1182/blood.2022017035.
Blood. 2023.
PMID: 36548957
Free PMC article.
Review.
Item in Clipboard
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial.
Kopmar NE, Quach K, Gooley TA, Martino CH, Cherian S, Percival MM, Halpern AB, Ghiuzeli CM, Oehler VG, Abkowitz JL, Walter RB, Cassaday RD.
Kopmar NE, et al.
JAMA Oncol. 2024 May 9:e240967. doi: 10.1001/jamaoncol.2024.0967. Online ahead of print.
JAMA Oncol. 2024.
PMID: 38722664
Item in Clipboard
Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms.
Kopmar NE, Othus M, Quach K, Rasmussen A, Schonhoff K, Becker PS, Walter RB, Halpern AB, Salit R, Cassaday RD, Shustov A, Stewart FM, Oehler VG, Scott BL, Sandmaier BM, Lee SJ, Estey EH, Percival MM.
Kopmar NE, et al.
Transplant Cell Ther. 2024 May 5:S2666-6367(24)00376-2. doi: 10.1016/j.jtct.2024.05.002. Online ahead of print.
Transplant Cell Ther. 2024.
PMID: 38710302
Item in Clipboard
Cite
Cite